Cost-Effectiveness of Olanzapine as First-Line Treatment for Schizophrenia: Results from a Randomized, Open-Label, 1-Year Trial - Concepedia

Concepedia

Publication | Open Access

Cost-Effectiveness of Olanzapine as First-Line Treatment for Schizophrenia: Results from a Randomized, Open-Label, 1-Year Trial

DOI Full Paper Access

53

Citations

54

References

2005

Year

Sandra L. Tunis, Douglas E. Faries, Allen W. Nyhuis, Bruce J. Kinon, Haya Ascher‐Svanum, Ralph Aquila

Value in Health

PsychiatryHealth EconomicsPsychotropic MedicationPsychotic Disorder1-Year TrialPsychopharmacologySchizophreniaPharmacoeconomicsFirst-line TreatmentSocial SciencesMedicinePsychopathology

References

	Year	Citations

Page 1

Page 1